CAPROCK GROUP, LLC Vertex Pharmaceuticals Incorporated Transaction History

CAPROCK GROUP, LLC portfolio value:

$627,000
portfolio value

CAPROCK GROUP, LLC quarter portfolio value change:

+2.75%
quarter

Vertex Pharmaceuticals Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +1.93% 41 shares 29K $289.54 2.16K
Q2 2022 share Decrease -36.89% -1.24K shares -280K $281.79 2.12K
Q1 2022 share Decrease -1.58% -54 shares 127K $260.97 3.36K
Q4 2021 share Increase +133.63% 1.95K shares 486K $222.45 3.41K
Q3 2021 share Decrease -18.95% -342 shares -99K $181.39 1.46K
Q2 2021 share Increase +21.96% 325 shares 46K $201.63 1.80K
Q1 2021 share Decrease -9.87% -162 shares -70K $214.89 1.48K
Q4 2020 share Decrease -21.59% -452 shares -182K $236.34 1.64K
Q3 2020 share Increase +12.34% 230 shares 29K $272.12 2.09K
Q2 2020 share Increase 0.00% 1.86K shares 541K $290.31 1.86K